Comparing sST2 with the classical biomarkers (Troponin T and NTproBNP) in the prognostication of patients with heart failure with reduced ejection fraction
Changes in circulating miRNAs as a prognostic tool for heart failure related morbidity and mortality in patients suffering from stable HFpEF: A subgroup analysis of the ALDO-DHF trial